LLY
ELI LILLY & CoB7515-min delayed · EOD close1150.99 −1.64% downas of 2026-09-23mkt cap $1.1T
Pharmaceutical Preparations · SIC 2834 · CIK 0000059478
Quality score
75/100
B
Growth100
Business quality100
missing: grossMargin, operatingMargin
Financial healthno data
missing: debtToEquity, cashToLiabilities
Valuation26
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Solid, with a soft spot
Highly uneven
Strongest on growth (100), weakest on valuation (26). The composite is the mean of the sub-scores that could be computed. 4 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
92.0%
year over year
Earnings growth
160.4%
year over year